Synergistic activity of ceftazidime/avibactam combined with aztreonam against MBL-producing exoY+/exoT+/exoU+/exoS- extensively drug-resistant Pseudomonas aeruginosa
PurposeExtensively drug-resistant Pseudomonas aeruginosa (XDR-PA) has posed a great threat to public health due to their rising incidence and complicated resistance mechanisms and limited treatment options. XDR-PA has demonstrated high resistance rate to new antibiotic ceftazidime-avibactam (CZA). T...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2026-02-01
|
| Sarja: | Frontiers in Cellular and Infection Microbiology |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fcimb.2026.1737414/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
